MedPath

Investigating the effect of tacrolimus on fertility in wome

Phase 2
Recruiting
Conditions
Recurrent implantation failure.
Complication associated with artificial fertilization, unspecified
N98.9
Registration Number
IRCT20160422027520N22
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Disturbed ratio (Th1/Th2)
Patients who have experienced at least 3 consecutive implantation failures will be included in our study.
Patients who do not have any type of immunotherapy in their medical history will be included in the study.

Exclusion Criteria

Patients under 18 years old and over 41 years oldPatients who themselves or their spouses have abnormal karyotypes or genetic and chromosomal disorders.
Patients with coagulation problems.
Patients who have an underlying chronic disease and have to take special drugs.
Patients whose HIV, HCV or HBV test results are positive.
Patients who have a history of asthma and allergy to certain drugs.
Patients with intrauterine anomalies.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy rate. Timepoint: After positive beta-hCG test, clinical pregnancy was evaluated at 5-6 week. Method of measurement: Examining the formation of gestational sac using Sonography method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath